Logo image of DII-B.CA

DOREL INDUSTRIES-CL B (DII-B.CA) Stock Fundamental Analysis

TSX:DII-B - Toronto Stock Exchange - CA25822C2058 - Common Stock - Currency: CAD

3.9  -0.02 (-0.51%)

Fundamental Rating

1

DII-B gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 3 industry peers in the Household Durables industry. DII-B has a bad profitability rating. Also its financial health evaluation is rather negative. DII-B is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DII-B had negative earnings in the past year.
DII-B had a positive operating cash flow in the past year.
In the past 5 years DII-B reported 4 times negative net income.
DII-B had a positive operating cash flow in 4 of the past 5 years.
DII-B.CA Yearly Net Income VS EBIT VS OCF VS FCFDII-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200M -400M

1.2 Ratios

DII-B has a better Return On Assets (-11.16%) than 66.67% of its industry peers.
DII-B's Return On Equity of -85.19% is on the low side compared to the rest of the industry. DII-B is outperformed by 66.67% of its industry peers.
Industry RankSector Rank
ROA -11.16%
ROE -85.19%
ROIC N/A
ROA(3y)1.63%
ROA(5y)0.36%
ROE(3y)4.62%
ROE(5y)0.63%
ROIC(3y)N/A
ROIC(5y)N/A
DII-B.CA Yearly ROA, ROE, ROICDII-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 -60

1.3 Margins

The Gross Margin of DII-B (20.06%) is worse than 66.67% of its industry peers.
DII-B's Gross Margin has declined in the last couple of years.
DII-B does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.01%
GM growth 5Y-3.78%
DII-B.CA Yearly Profit, Operating, Gross MarginsDII-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

More info and screens

1

2. Health

2.1 Basic Checks

DII-B does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DII-B has about the same amount of shares outstanding.
DII-B has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, DII-B has an improved debt to assets ratio.
DII-B.CA Yearly Shares OutstandingDII-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
DII-B.CA Yearly Total Debt VS Total AssetsDII-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B

2.2 Solvency

Based on the Altman-Z score of 1.35, we must say that DII-B is in the distress zone and has some risk of bankruptcy.
DII-B has a better Altman-Z score (1.35) than 66.67% of its industry peers.
DII-B has a debt to FCF ratio of 49.55. This is a negative value and a sign of low solvency as DII-B would need 49.55 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 49.55, DII-B is doing worse than 66.67% of the companies in the same industry.
A Debt/Equity ratio of 1.14 is on the high side and indicates that DII-B has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.14, DII-B is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 49.55
Altman-Z 1.35
ROIC/WACCN/A
WACC6.44%
DII-B.CA Yearly LT Debt VS Equity VS FCFDII-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M 800M 1B

2.3 Liquidity

DII-B has a Current Ratio of 0.94. This is a bad value and indicates that DII-B is not financially healthy enough and could expect problems in meeting its short term obligations.
DII-B has a Current ratio of 0.94. This is in the lower half of the industry: DII-B underperforms 66.67% of its industry peers.
DII-B has a Quick Ratio of 0.94. This is a bad value and indicates that DII-B is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of DII-B (0.46) is worse than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.46
DII-B.CA Yearly Current Assets VS Current LiabilitesDII-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

More info and screens

3

3. Growth

3.1 Past

DII-B shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 48.68%, which is quite impressive.
DII-B shows a small growth in Revenue. In the last year, the Revenue has grown by 1.87%.
The Revenue for DII-B have been decreasing by -11.92% on average. This is quite bad
EPS 1Y (TTM)48.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-93.75%
Revenue 1Y (TTM)1.87%
Revenue growth 3Y-20.49%
Revenue growth 5Y-11.92%
Sales Q2Q%-1.51%

3.2 Future

DII-B is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.25% yearly.
The Revenue is expected to grow by 2.47% on average over the next years.
EPS Next Y0.45%
EPS Next 2Y33.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.56%
Revenue Next 2Y2.47%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DII-B.CA Yearly Revenue VS EstimatesDII-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
DII-B.CA Yearly EPS VS EstimatesDII-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DII-B. In the last year negative earnings were reported.
Also next year DII-B is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DII-B.CA Price Earnings VS Forward Price EarningsDII-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DII-B indicates a somewhat cheap valuation: DII-B is cheaper than 66.67% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, DII-B is valued a bit more expensive than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.79
EV/EBITDA 7.65
DII-B.CA Per share dataDII-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

DII-B's earnings are expected to grow with 33.25% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.25%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DII-B!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DOREL INDUSTRIES-CL B

TSX:DII-B (3/7/2025, 7:00:00 PM)

3.9

-0.02 (-0.51%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)11-14 2024-11-14/bmo
Earnings (Next)03-11 2025-03-11/amc
Inst Owners47.34%
Inst Owner ChangeN/A
Ins Owners1.3%
Ins Owner ChangeN/A
Market Cap127.26M
Analysts42.5
Price Target4.59 (17.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1148.87%
Min EPS beat(2)-2106.47%
Max EPS beat(2)-191.26%
EPS beat(4)1
Avg EPS beat(4)-599.85%
Min EPS beat(4)-2106.47%
Max EPS beat(4)113.87%
EPS beat(8)1
Avg EPS beat(8)-405.13%
EPS beat(12)1
Avg EPS beat(12)-1263.21%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.86%
Min Revenue beat(2)-7.3%
Max Revenue beat(2)-6.41%
Revenue beat(4)0
Avg Revenue beat(4)-5.3%
Min Revenue beat(4)-7.3%
Max Revenue beat(4)-2.34%
Revenue beat(8)0
Avg Revenue beat(8)-11.68%
Revenue beat(12)0
Avg Revenue beat(12)-11%
Revenue beat(16)1
Avg Revenue beat(16)-13.87%
PT rev (1m)0%
PT rev (3m)-5.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.06
P/FCF 10.79
P/OCF 2.51
P/B 0.74
P/tB 1.52
EV/EBITDA 7.65
EPS(TTM)-2.22
EYN/A
EPS(NY)-0.58
Fwd EYN/A
FCF(TTM)0.36
FCFY9.27%
OCF(TTM)1.56
OCFY39.89%
SpS61.69
BVpS5.3
TBVpS2.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.16%
ROE -85.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.06%
FCFM 0.59%
ROA(3y)1.63%
ROA(5y)0.36%
ROE(3y)4.62%
ROE(5y)0.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.01%
GM growth 5Y-3.78%
F-Score5
Asset Turnover1.52
Health
Industry RankSector Rank
Debt/Equity 1.14
Debt/FCF 49.55
Debt/EBITDA 2.28
Cap/Depr 39.05%
Cap/Sales 1.94%
Interest Coverage N/A
Cash Conversion 58.62%
Profit Quality N/A
Current Ratio 0.94
Quick Ratio 0.46
Altman-Z 1.35
F-Score5
WACC6.44%
ROIC/WACCN/A
Cap/Depr(3y)38.59%
Cap/Depr(5y)37.96%
Cap/Sales(3y)1.84%
Cap/Sales(5y)1.64%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-93.75%
EPS Next Y0.45%
EPS Next 2Y33.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.87%
Revenue growth 3Y-20.49%
Revenue growth 5Y-11.92%
Sales Q2Q%-1.51%
Revenue Next Year0.56%
Revenue Next 2Y2.47%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y87.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year232.11%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y105.08%
FCF growth 3Y-19.09%
FCF growth 5Y-0.88%
OCF growth 1Y127.19%
OCF growth 3Y-16.99%
OCF growth 5Y-6.95%